V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017494 | 220008189 | 1.67 | 20.5 | Disease modification (D) | 2016-08-18 | 2016-08-18 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220031094 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017495 | 220008190 | 0 | 53.1 | Curative (C) | 2017-10-15 | 2018-03-02 | IDARUBICIN + TRETINOIN | N | N | 220031102 | IDARUBICIN + TRETINOIN |
| 220017497 | 220017900 | 0 | 75 | Curative (C) | null | 2017-02-13 | Cyclophosphamide TBI Allograft | N | Y | 220031113 | CYCLOPHOSPHAMIDE |
| 220017498 | 220008200 | 1.94 | 71.45 | null | 2018-01-18 | 2018-10-12 | ATG + Busulfan + Fludarabine | N | N | 220031142 | ATG + BUSULFAN + FLUDARABINE |
| 220017499 | 220008200 | 1.79 | 77.4 | Curative (C) | 2017-09-08 | 2017-09-08 | ATG + Busulfan + Fludarabine | 01 | N | 220031142 | ATG + BUSULFAN + FLUDARABINE |
| 220017500 | 220014473 | 1.54 | null | null | 2017-09-08 | 2017-09-13 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220031173 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017501 | 220008203 | 1.75 | null | Curative (C) | 2016-08-08 | 2016-08-09 | Cyclophosphamide+Fludara+TBI Allo | null | N | 220031195 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017502 | 220008205 | 1.67 | 85 | Curative (C) | 2015-06-21 | 2015-06-21 | FLAG | N | N | 220031209 | FLAG |
| 220017504 | 220008209 | 1.78 | null | Adjuvant (A) | 2016-08-25 | 2016-12-19 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220031213 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017505 | 220008210 | null | 67 | Disease modification (D) | null | 2018-03-18 | BOSUTINIB | null | null | 220031213 | BOSUTINIB |
| 220017506 | 220008212 | 1.87 | 65 | Curative (C) | 2015-10-12 | 2015-11-27 | FLAG | N | N | 220031221 | FLAG |
| 220017507 | 220008214 | 1.83 | 23.1 | Disease modification (D) | 2016-03-31 | 2016-06-13 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031225 | IDARUBICIN + TRETINOIN |
| 220017508 | 220008216 | 1.73 | 71 | Curative (C) | 2017-10-01 | 2017-10-06 | AML16 DA 3+8 | N | N | 220031230 | AML16 TRIAL |
| 220017511 | 220008221 | 1.6 | null | Curative (C) | 2018-08-04 | 2018-08-06 | BOSUTINIB | 02 | N | 220031249 | BOSUTINIB |
| 220017512 | 220014481 | null | 92.1 | Curative (C) | 2019-02-15 | 2019-03-25 | FLAG | N | null | 220031249 | FLAG |
| 220017513 | 220014482 | 1.75 | 83.1 | Curative (C) | 2016-02-28 | 2016-03-07 | CYCLOPHOSPHAMIDE | 02 | N | 220031254 | CYCLOPHOSPHAMIDE |
| 220017514 | 220014482 | 1.63 | 87.6 | Curative (C) | 2016-08-06 | 2017-03-10 | RUXOLITINIB | N | N | 220031254 | RUXOLITINIB |
| 220017515 | 220019830 | 1.8 | 70.95 | Palliative (P) | 2014-03-24 | 2014-05-08 | AML Int Guide ADE 8+3+5 (2) | N | N | 220031258 | ADE |
| 220017518 | 220008231 | null | 92.1 | Curative (C) | 2014-04-14 | 2014-06-22 | FLAG | Y | Y | 220031285 | FLAG |
| 220017519 | 220008232 | 1.84 | null | Curative (C) | 2015-06-15 | 2015-10-06 | CYCLOPHOSPHAMIDE + FLUDARABINE | Y | null | 220031293 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017520 | 220008233 | 1.67 | 69.7 | null | 2016-06-13 | 2016-08-28 | Cyclophosphamide+Fludara+TBI Allo | 99 | N | 220031294 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017521 | 220008235 | 0 | 52.5 | Curative (C) | 2015-09-03 | 2015-09-06 | Methotrexate intrathecal | 2 | N | 220031299 | METHOTREXATE INTRATHECAL |
| 220017522 | 220008240 | null | 93 | Curative (C) | 2014-08-03 | 2014-08-03 | FLAG | null | null | 220031302 | FLAG |
| 220017523 | 220008243 | null | 85 | Curative (C) | 2014-11-09 | 2014-11-10 | Cyclophosphamide+Fludara+TBI Allo | 01 | N | 220031309 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017524 | 220020938 | null | 93.4 | Curative (C) | 2017-08-28 | 2017-09-01 | BOSUTINIB | N | N | 220031331 | BOSUTINIB |
| 220017525 | 220021903 | 1.17 | 55 | Curative (C) | 2017-05-27 | 2017-05-29 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | 220031335 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017526 | 220014492 | 1.79 | 85.2 | Curative (C) | 2017-06-27 | 2017-07-08 | BOSUTINIB | 2 | N | 220031344 | BOSUTINIB |
| 220017528 | 220014493 | null | 74.1 | Curative (C) | 2016-04-28 | 2016-04-29 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220031352 | IDARUBICIN + TRETINOIN |
| 220017529 | 220008251 | 1.59 | 46.9 | Curative (C) | 2015-08-23 | 2015-08-23 | Methotrexate intrathecal | N | null | 220031392 | METHOTREXATE INTRATHECAL |
| 220017530 | 220008256 | 1.81 | 61.5 | Curative (C) | 2017-01-18 | 2017-01-18 | AML16 DA 3+8 | N | N | 220031393 | AML16 TRIAL |
| 220017531 | 220008258 | 1.81 | 71.55 | Curative (C) | 2016-01-27 | 2016-01-27 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220031398 | IDARUBICIN + TRETINOIN |
| 220017532 | 220008259 | 1.67 | null | Curative (C) | 2016-05-11 | 2016-08-31 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 220031399 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017534 | 220008262 | 1.71 | null | Curative (C) | 2017-04-25 | 2017-04-25 | AML Int Guide ADE 8+3+5 (2) | N | N | 220031403 | ADE |
| 220017535 | 220017922 | 1.69 | 60.5 | Curative (C) | null | 2015-12-02 | Idarubicin+Tretinoin Spanish Crse2 | 02 | null | 220031416 | IDARUBICIN + TRETINOIN |
| 220017536 | 220017922 | 1.43 | 53.6 | Disease modification (D) | 2013-09-22 | 2018-01-10 | BOSUTINIB | N | N | 220031416 | BOSUTINIB |
| 220017537 | 220008270 | null | null | Curative (C) | 2014-05-26 | 2014-05-29 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220031435 | IDARUBICIN + TRETINOIN |
| 220017538 | 220014503 | null | 97 | Curative (C) | null | 2015-09-26 | AML16 Azacitidine | Y | N | 220031441 | AML16 TRIAL |
| 220017539 | 220008276 | 1.8 | 90 | Curative (C) | 2014-03-09 | 2014-05-03 | AML16 DA 3+8 | N | N | 220031455 | AML16 TRIAL |
| 220017541 | 220008282 | 1.7 | 83.2 | Curative (C) | 2016-09-20 | 2016-09-20 | Methotrexate intrathecal | N | N | 220031480 | METHOTREXATE INTRATHECAL |
| 220017542 | 220014507 | 1.82 | 60.9 | Curative (C) | 2014-09-28 | 2014-09-28 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220031482 | IDARUBICIN + TRETINOIN |
| 220017543 | 220008286 | null | 64.7 | Curative (C) | 2017-07-05 | 2017-07-07 | Methotrexate intrathecal | null | null | 220031491 | METHOTREXATE INTRATHECAL |
| 220017544 | 220008290 | 1.55 | 55.5 | Curative (C) | null | 2017-05-25 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220031493 | IDARUBICIN + TRETINOIN |
| 220017545 | 220008291 | null | 16.6 | Curative (C) | 2017-06-30 | 2017-07-03 | BOSUTINIB | N | null | 220031504 | BOSUTINIB |
| 220017546 | 220008292 | 1.98 | 103.3 | Curative (C) | 2013-07-06 | 2013-07-12 | Idarubicin+Tretinoin Spanish Crse4 | Y | N | 220031508 | IDARUBICIN + TRETINOIN |
| 220017547 | 220008294 | 1.65 | 83.7 | Not known (9) | null | 2019-01-28 | AML16 Low Dose Cytarabine | N | null | 220031509 | AML16 TRIAL |
| 220017548 | 220014510 | 1 | 68 | Not known (9) | 2018-06-23 | 2018-06-23 | Idarubicin+Tretinoin Spanish Crse4 | Y | null | 220031510 | IDARUBICIN + TRETINOIN |
| 220017549 | 220017928 | 1.57 | null | Curative (C) | 2016-08-09 | 2016-08-15 | AML16 Low Dose Cytarabine | N | N | 220031527 | AML16 TRIAL |
| 220017550 | 220008300 | 1.5 | 66.2 | Curative (C) | 2013-04-25 | 2013-08-11 | IDARUBICIN + TRETINOIN | N | N | 220031530 | IDARUBICIN + TRETINOIN |
| 220017551 | 220008304 | null | 55 | Neo-adjuvant (N) | 2015-12-28 | 2016-01-04 | IDARUBICIN + TRETINOIN | 99 | null | 220031551 | IDARUBICIN + TRETINOIN |
| 220017552 | 220014513 | 1.59 | null | Curative (C) | 2012-07-17 | 2013-10-05 | Cyclophosphamide TBI Allograft | 02 | null | 220031562 | CYCLOPHOSPHAMIDE |